Current and emerging treatment options in the management of lupus
Natasha Jordan,1 David D’Cruz2 1Department of Rheumatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, 2Louise Coote Lupus Unit, Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, UK Abstract: Systemic lupus erythematosus (SLE) is a comple...
Main Authors: | Jordan N, D’Cruz D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/current-and-emerging-treatment-options-in-the-management-of-lupus-peer-reviewed-article-ITT |
Similar Items
-
Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01) -
Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
by: Khalaf Kridin, et al.
Published: (2021-09-01) -
Intersticial pulmonary disease in patients with systemic sclerosis. Narrative review of the literature
by: Álvarez-Barreneche, María Fernanda, et al.
Published: (2017-07-01) -
Granulomatosis with polyangiitis – therapeutic challenge
by: Dorota Szydlarska, et al.
Published: (2016-02-01) -
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)